Literature DB >> 19097085

Transplantation of human embryonic stem cell-derived endothelial cells for vascular diseases.

Zongjin Li1, Zhongchao Han, Joseph C Wu.   

Abstract

Using endothelial cells for therapeutic angiogenesis/vasculogenesis of ischemia diseases has led to exploring human embryonic stem cells (hESCs) as a potentially unlimited source for endothelial progenitor cells. With their capacity for self-renewal and pluripotency, hESCs and their derived endothelial cells (hESC-ECs) may be more advantageous than other endothelial cells obtained from diseased populations. However, hESC-ECs' poor differentiation efficiency and poorly characterized in vivo function after transplantation present significant challenges for their future clinical application. This review will focus on the differentiation pathways of hESCs and their therapeutic potential for vascular diseases, as well as the monitoring of transplanted cells' fate via molecular imaging. Finally, cell enhancement strategies to improve the engraftment efficiency of hESC-ECs will be discussed.

Entities:  

Mesh：

Year:  2009        PMID： 19097085      PMCID： PMC2866109          DOI： 10.1002/jcb.22003

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN： 0730-2312            Impact factor:   4.429


  44 in total

1.  Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo.

Authors:  Zack Z Wang; Patrick Au; Tong Chen; Ying Shao; Laurence M Daheron; Hao Bai; Melanie Arzigian; Dai Fukumura; Rakesh K Jain; David T Scadden
Journal:  Nat Biotechnol       Date:  2007-02-25       Impact factor: 54.908

2.  Cell-cell and cell-extracellular matrix interactions regulate embryonic stem cell differentiation.

Authors:  Silvia S Chen; Wendy Fitzgerald; Joshua Zimmerberg; Hynda K Kleinman; Leonid Margolis
Journal:  Stem Cells       Date:  2007-03       Impact factor: 6.277

3.  G-CSF-mobilized peripheral blood mononuclear cells from diabetic patients augment neovascularization in ischemic limbs but with impaired capability.

Authors:  B Zhou; Y Y Bi; Z B Han; H Ren; Z H Fang; X F Yu; M-C Poon; Z C Han
Journal:  J Thromb Haemost       Date:  2006-05       Impact factor: 5.824

4.  Stromal cell-derived factor-1/CXCR4 signaling modifies the capillary-like organization of human embryonic stem cell-derived endothelium in vitro.

Authors:  Tong Chen; Hao Bai; Ying Shao; Melanie Arzigian; Viktor Janzen; Eyal Attar; Yi Xie; David T Scadden; Zack Z Wang
Journal:  Stem Cells       Date:  2006-10-12       Impact factor: 6.277

5.  Derivation of human embryonic stem cells in defined conditions.

Authors:  Tenneille E Ludwig; Mark E Levenstein; Jeffrey M Jones; W Travis Berggren; Erika R Mitchen; Jennifer L Frane; Leann J Crandall; Christine A Daigh; Kevin R Conard; Marian S Piekarczyk; Rachel A Llanas; James A Thomson
Journal:  Nat Biotechnol       Date:  2006-01-01       Impact factor: 54.908

6.  Generation of functional hemangioblasts from human embryonic stem cells.

Authors:  Shi-Jiang Lu; Qiang Feng; Sergio Caballero; Yu Chen; Malcolm A S Moore; Maria B Grant; Robert Lanza
Journal:  Nat Methods       Date:  2007-05-07       Impact factor: 28.547

7.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

8.  Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential.

Authors:  Maxim A Vodyanik; Jack A Bork; James A Thomson; Igor I Slukvin
Journal:  Blood       Date:  2004-09-16       Impact factor: 22.113

9.  Simultaneous differentiation of endothelial and trophoblastic cells derived from human embryonic stem cells.

Authors:  Isabelle Peiffer; Denis Belhomme; Romain Barbet; Valerie Haydont; Yi-Ping Zhou; Nicolas O Fortunel; Malin Li; Antoinette Hatzfeld; Jean-Noel Fabiani; Jacques A Hatzfeld
Journal:  Stem Cells Dev       Date:  2007-06       Impact factor: 3.272

10.  Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease.

Authors:  Zongjin Li; Jenny C Wu; Ahmad Y Sheikh; Daniel Kraft; Feng Cao; Xiaoyan Xie; Manishkumar Patel; Sanjiv S Gambhir; Robert C Robbins; John P Cooke; Joseph C Wu
Journal:  Circulation       Date:  2007-09-11       Impact factor: 29.690
View more
  19 in total

1.  Functional characterization of embryonic stem cell-derived endothelial cells.

Authors:  Drew E Glaser; Robert M Gower; Nicholas E Lauer; Kayan Tam; Alicia A Blancas; Albert J Shih; Scott I Simon; Kara E McCloskey
Journal:  J Vasc Res       Date:  2011-05-31       Impact factor: 1.934

2.  Bioengineering heart muscle: a paradigm for regenerative medicine.

Authors:  Gordana Vunjak-Novakovic; Kathy O Lui; Nina Tandon; Kenneth R Chien
Journal:  Annu Rev Biomed Eng       Date:  2011-08-15       Impact factor: 9.590

3.  IGF-1 C Domain-Modified Hydrogel Enhances Cell Therapy for AKI.

Authors:  Guowei Feng; Jimin Zhang; Yang Li; Yan Nie; Dashuai Zhu; Ran Wang; Jianfeng Liu; Jie Gao; Na Liu; Ningning He; Wei Du; Hongyan Tao; Yongzhe Che; Yong Xu; Deling Kong; Qiang Zhao; Zongjin Li
Journal:  J Am Soc Nephrol       Date:  2016-02-11       Impact factor: 10.121

4.  Bioluminescence reporter gene imaging characterize human embryonic stem cell-derived teratoma formation.

Authors:  Weijun Su; Manqian Zhou; Yizhou Zheng; Yan Fan; Lina Wang; Zhongchao Han; Deling Kong; Robert Chunhua Zhao; Joseph C Wu; Rong Xiang; Zongjin Li
Journal:  J Cell Biochem       Date:  2011-03       Impact factor: 4.429

5.  High-purity enrichment of functional cardiovascular cells from human iPS cells.

Authors:  Bo Lin; Jong Kim; Yanxin Li; Haiying Pan; Xonia Carvajal-Vergara; Guy Salama; Tao Cheng; Yong Li; Cecilia W Lo; Lei Yang
Journal:  Cardiovasc Res       Date:  2012-06-06       Impact factor: 10.787

6.  Improved mesenchymal stem cell survival in ischemic heart through electroacupuncture.

Authors:  Jin Zhang; Xiao-Hua Jia; Zhi-Wei Xu; Fu-Ping Ding; Xin Zhou; Hao Fu; Yi Liu; Lai-Liang Ou; Zong-Jin Li; De-Ling Kong
Journal:  Chin J Integr Med       Date:  2012-08-18       Impact factor: 1.978

Review 7.  Pluripotent Stem Cell Therapy in Ischemic Cardiovascular Disease.

Authors:  Ting-Hsing Chao; I-Chih Chen; Shi-Ya Tseng; Yi-Heng Li
Journal:  Acta Cardiol Sin       Date:  2014-09       Impact factor: 2.672

8.  Antitumor effects of CD40 ligand-expressing endothelial progenitor cells derived from human induced pluripotent stem cells in a metastatic breast cancer model.

Authors:  Yovita Ida Purwanti; Can Chen; Dang Hoang Lam; Chunxiao Wu; Jieming Zeng; Weimin Fan; Shu Wang
Journal:  Stem Cells Transl Med       Date:  2014-06-27       Impact factor: 6.940

9.  Fate mapping of human embryonic stem cells by teratoma formation.

Authors:  Carissa Ritner; Harold S Bernstein
Journal:  J Vis Exp       Date:  2010-08-01       Impact factor: 1.355

10.  Functional and transcriptional characterization of human embryonic stem cell-derived endothelial cells for treatment of myocardial infarction.

Authors:  Zongjin Li; Kitchener D Wilson; Bryan Smith; Daniel L Kraft; Fangjun Jia; Mei Huang; Xiaoyan Xie; Robert C Robbins; Sanjiv S Gambhir; Irving L Weissman; Joseph C Wu
Journal:  PLoS One       Date:  2009-12-31       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.